Terms: = Uterine cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1
167 results:
1. Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs.
Santoro A; Bragantini E; Castiglione F; Ganesan R; Matias-Guiu X; Frattini M; Gallotta V; Garcia P; Pattni Y; Tsiampali-Laprell J; Bisaro B; Barbareschi M; Zannoni GF;
Pathologica; 2024 Feb; 116(1):32-45. PubMed ID: 38482673
[TBL] [Abstract] [Full Text] [Related]
2. Evaluating the Prognostic Factors and Survival Rates of Endometrial cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.
Wannasin R; Thinkhamrop K; Kelly M; Likitdee N
Asian Pac J Cancer Prev; 2024 Feb; 25(2):671-679. PubMed ID: 38415555
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations.
Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
[TBL] [Abstract] [Full Text] [Related]
4. Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.
Papadopoulou E; Rigas G; Fountzilas E; Boutis A; Giassas S; Mitsimponas N; Daliani D; Ziogas DC; Liontos M; Ramfidis V; Christophilakis C; Matthaios D; Floros T; Florou-Chatzigiannidou C; Agiannitopoulos K; Meintani A; Tsantikidi A; Katseli A; Potska K; Tsaousis G; Metaxa-Mariatou V; Nasioulas G
JCO Precis Oncol; 2024 Jan; 8():e2300332. PubMed ID: 38271656
[TBL] [Abstract] [Full Text] [Related]
5. Correlation analysis of risk factors for cervical lymphatic metastasis in papillary thyroid carcinoma.
Sun H; Zhao X; Wang X; Ma J; Liu M
Diagn Pathol; 2024 Jan; 19(1):13. PubMed ID: 38218832
[TBL] [Abstract] [Full Text] [Related]
6. Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review.
Ribeiro LM; Bomtempo FF; Rocha RB; Telles JPM; Neto EB; Figueiredo EG
Clin Exp Metastasis; 2023 Dec; 40(6):445-463. PubMed ID: 37819546
[TBL] [Abstract] [Full Text] [Related]
7. Cervical HPV infection in Yueyang, China: a cross-sectional study of 125,604 women from 2019 to 2022.
Hou J; Zeng M; Liu C; Xie B; Li Y; Wu L; Zhu L; Li M; Zhang Z; Zhang X; Ge Y
Front Public Health; 2023; 11():1210253. PubMed ID: 37601194
[TBL] [Abstract] [Full Text] [Related]
8. Patterns of lymph node metastasis in level IIB and contralateral level VI for papillary thyroid carcinoma with pN1b and safety of low collar extended incision for neck dissection in level II.
Ning Y; Liu Y; Zeng D; Zhou Y; Ma L; Dong S; Sheng J; Wu G; Tian W; Cai Y; Li C
World J Surg Oncol; 2023 Aug; 21(1):249. PubMed ID: 37592337
[TBL] [Abstract] [Full Text] [Related]
9. Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical cancer in Women With High-Risk Human Papillomavirus Infection.
Xiao T; Wang C; Yang M; Yang J; Xu X; Shen L; Yang Z; Xing H; Ou CQ
JAMA Netw Open; 2023 Aug; 6(8):e2326890. PubMed ID: 37531108
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract] [Full Text] [Related]
11. Breast, cervical, and colorectal cancer screening test use in the US territories of Guam, Puerto Rico, and the US Virgin Islands.
Gopalani SV; Soman A; Shapiro JA; Miller JW; Ortiz-Ortiz KJ; Castañeda-Avila MA; Buenconsejo-Lum LE; Fredericks LE; Tortolero-Luna G; Saraiya M
Cancer Epidemiol; 2023 Jun; 84():102371. PubMed ID: 37105018
[TBL] [Abstract] [Full Text] [Related]
12. Cytotoxic Effects of Combinative ZnPcS
Razlog R; Kruger CA; Abrahamse H
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047123
[TBL] [Abstract] [Full Text] [Related]
13. Value of TCT combined with HPV and CA125 in early cervical cancer screening in a medical examination population.
Xiao M; Zhang Z; Yu X; Fan Y; Chen X
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):160-164. PubMed ID: 36905257
[TBL] [Abstract] [Full Text] [Related]
14. Erdheim-Chester Disease Involving the Left uterine Adnexa: Mimicking an Ovarian Carcinoma Clinically.
Zeng Y; Wang Q; Wang X; Jiang X; Yao H; Tang X
Int J Surg Pathol; 2023 Dec; 31(8):1532-1537. PubMed ID: 36855299
[TBL] [Abstract] [Full Text] [Related]
15. Senolytic Therapy: A Potential Approach for the Elimination of Oncogene-Induced Senescent HPV-Positive Cells.
Saleh T; Khasawneh AI; Himsawi N; Abu-Raideh J; Ejeilat V; Elshazly AM; Gewirtz DA
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555154
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of Effectiveness as well as Advantages and Disadvantages of Different Dimensions of Hysterosalpingo-Contrast Sonography for Diagnosis of Lesions Associated with Female Infertility.
Pei R
Comput Math Methods Med; 2022; 2022():7508880. PubMed ID: 36164612
[TBL] [Abstract] [Full Text] [Related]
17. Cervical cancer management in Zimbabwe (2019-2020).
Zibako P; Tsikai N; Manyame S; Ginindza TG
PLoS One; 2022; 17(9):e0274884. PubMed ID: 36129898
[TBL] [Abstract] [Full Text] [Related]
18. PRAME Expression in cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors.
Kaczorowski M; Chłopek M; Kruczak A; Ryś J; Lasota J; Miettinen M
Am J Surg Pathol; 2022 Nov; 46(11):1467-1476. PubMed ID: 35973038
[TBL] [Abstract] [Full Text] [Related]
19. Relugolix Combination Therapy for uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.
Stewart EA; Lukes AS; Venturella R; Arjona Ferreira JC; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Obstet Gynecol; 2022 Jun; 139(6):1070-1081. PubMed ID: 35675604
[TBL] [Abstract] [Full Text] [Related]
20. Trends in guideline-adherent chemoradiation therapy for locally advanced cervical cancer before and after the affordable care act.
Thomas RJ; Provenzano D; Goyal S; Loew M; Lopez-Acevedo M; Long B; Chappell NP; Rao YJ
Gynecol Oncol; 2022 Jul; 166(1):165-172. PubMed ID: 35491268
[TBL] [Abstract] [Full Text] [Related]
[Next]
